Outcomes of Placenta Accreta Spectrum Disorders Surgery in Relation to Placenta Accreta Scoring Index
Launched by ASSIUT UNIVERSITY · Jan 14, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how ultrasound can help predict the outcomes of surgery for women with a condition called placenta accreta, which occurs when the placenta attaches too deeply into the uterus. The research will focus on women who have placenta previa, a situation where the placenta is positioned low in the uterus, and who have had at least one previous cesarean section. By using a specific scoring system based on ultrasound images, the study aims to see how well this method can forecast the success of the surgery needed to treat these conditions.
To be eligible for this trial, participants must be pregnant women who are at least 32 weeks along in their pregnancy, carrying a single baby, and diagnosed with placenta previa. Unfortunately, women who are in active labor or have unstable medical conditions cannot take part in the study. Those who do participate can expect to undergo ultrasound examinations to assess their situation, which may help doctors better plan for their surgery and improve outcomes. The trial is not yet recruiting participants, but it aims to provide valuable insights for future treatments in this area.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. pregnant women with gestational age 32 weeks or more
- • 2. singleton pregnancy
- • 3. known to have placenta previa (lower edge of the placenta within 5 cm from internal Os )
- • 4. with at least previous 1 cesarean section
- Exclusion Criteria:
- • 1. the patient is active in labor
- • 2. haemodynamically unstable
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mohammed Nagy, MD
Study Chair
Assiut University
Mansour Khalifa, MD
Study Director
Assiut University
Mostafa Hussien, MD
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported